| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Andrew I McDonald last filed a Form 4 in May 2022, as Director at VINC. Andrew I McDonald's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 20,000 shares of VINC. Net of sales, the VINC filings show accumulation of 20,000 shares.
Andrew I McDonald has 6 Form 4 filings on record from March 2020 to May 2022, all as Director, 10% Owner at Vincerx Pharma (VINC), 2020–2022.
The 7 reported transactions were 4 option or other derivative awards, 2 other transactions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $248K and no sales.
The only open-market purchase was 20,000 shares of VINC at an average $12.38 on June 29, 2021, about $248K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | VINC Vincerx Pharma, Inc. | Director | Buy | 20,000 | $12.38 | $247,600.00 | New |